Interspecialty and intraspecialty differences in the management of thyroid nodular disease and cancer
β Scribed by Jonathan R. Clark; Jeremy L. Freeman
- Book ID
- 102847526
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 1013 KB
- Volume
- 27
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
β¦ Synopsis
Introduction:
The management of thyroid cancer includes multiple medical specialties. physicians from different specialties may vary in opinion regarding the optimal investigation and treatment of patients. little data exist evaluating the differences within or between various specialties treating thyroid disease. this study aims to examine responses from a variety of specialty physicians closely involved in the medical or surgical management of thyroid disease to provide evidence as to whether any difference exists.
Methods:
A cross-sectional survey of attendees at the 5(th) biennial course on the management of thyroid nodular disease and cancer was conducted using an anonymous electronic touch pad system. touch pads were given to 213 attendees who were asked to respond to 44 questions. this study analyzes the responses obtained from 19 selected questions (43%) and compares the results between endocrinologists (n = 48), general surgeons (n = 41), otolaryngologists (n = 61), and pathologists (n = 20).
Results:
Responses were obtained from 69% of endocrinologists, 68% of general surgeons, 72% of otolaryngologists, and 65% of pathologists. statistically significant interspecialty differences were observed in 12 (63%) of 19 questions. each question and a summary of responses from all touch pads were recorded.
Conclusions:
Significant differences in the attitudes toward, and presumably the practice of, managing thyroid nodular disease and cancer exist between specialties. an understanding of these differences is helpful when working as a multidisciplinary team to optimize patient care.
π SIMILAR VOLUMES
Fine needle aspiration biopsy (FNAB) performed for diffuse and nodular goiter in the past 5 years, was evaluated in 1399 cases. Surgery was performed on the basis of FNAB cytologic diagnosis that was positive or suggestive of malignancy and/or a suggestive clinical history. Surgery also was performe
Well-differentiated thyroid cancers (papillary, follicular, and some Hurthle cell tumors) contain membrane receptors for TSH. Responsiveness of these tumors to TSH stimuli is documented by increased radioactive iodine uptake, secretion of thyroglobulin, increase in thyroid size, and potential progre